Sun Pharma – Bringing 4,500 staff to visit Vietnam!

Introduce

Sun Pharmaceutical Industries Ltd (Sun Pharma), a multinational pharmaceutical giant founded in 1983 by billionaire Dilip Shanghvi, has established itself as a prominent player in the global healthcare market. With a revenue of over $5.4 billion, Sun Pharma operates in more than 100 countries and has 43 manufacturing facilities around the world. The company is well known for the high quality and affordability of its products in the fields of dermatology, oncology and ophthalmology.

Interesting facts about Sun Pharma

1. Established in 1983: The company was founded by Dilip Shanghvi in ​​Vapi, Gujarat, India. Initially, the company operated with a modest workforce of just two dedicated individuals, focusing its efforts on the specialized field of psychiatric medication
2. Rapid Development: By 1991, the company had established its first research center and began to expand its product portfolio. The company has a global network of member companies.
3. Strong M&A activity: In 2014, the company completed the acquisition of Ranbaxy Laboratories for $4 billion. This strategic move propelled Sun Pharma to the forefront of the Indian pharmaceutical industry, solidifying its position as one of the world’s largest generic drug companies. The company’s global expansion strategy has been further bolstered by its acquisition of Libra Merger (2024), Vivaldis (2023), Concert Pharmaceuticals (valued at $576 million in 2023), and Taro Pharmaceutical Industries Ltd. (valued at $348 million in 2024).
4. Global expansion: Sun Pharma’s global footprint is extensive, with operations spanning over 100 countries and a network of more than 40 manufacturing facilities worldwide. Notable subsidiaries and industry leaders under the Sun Pharma umbrella include Taro Pharmaceutical Industries Ltd. (Israel), Ranbaxy Laboratories (India), Concert Pharmaceuticals (USA), Alchemee LLC (USA), and various Sun Pharma entities in Canada, China, Japan, the UK, Australia, the Netherlands, Peru, Mexico, Venezuela, Kenya, the Philippines, Switzerland, France, the USA, Egypt, and Bangladesh….
5. Investment in research and development: The company is committed to investing heavily in research and development, with more than 30 research centers located across the globe. Sun Pharma’s core business is the development of specialty generics and novel drug delivery systems (NDDS). The company employs a team of over 2,800 scientists at six research and development centers in India, Israel, the United States, and Canada. These research efforts have enabled Sun Pharma to acquire nearly 1,600 global patents, which have been approved and recognized by agencies such as the FDA and European agencies.
6. Diverse products: Sun Pharma boasts a diverse and comprehensive product portfolio, encompassing an extensive range of over 2,000 distinct generic drugs, specialty drugs, and healthcare products.
7. The company is bringing 4,500 employees to Vietnam for a tourism-related business trip. In a testament to its dedication to employee well-being and fostering a positive corporate culture, Sun Pharma is organizing a significant tourism-related business trip to Vietnam for an impressive 4,500 employees. This initiative transcends the traditional purpose of leisure and entertainment, serving as a strategic endeavor to reinforce the company’s commitment to cultivating a cohesive and harmonious work environment. By investing in employee satisfaction and engagement, Sun Pharma aims to retain and motivate its talented workforce, recognizing the pivotal role that employees play in the company’s continued success and growth

In summary, the organization of this large-scale tour also serves to demonstrate Sun Pharma’s robust financial potential and effective management capabilities, affirming their position in the global pharmaceutical market and leaving a strong impression on partners and employees.

References:

• Tỉ phú Ấn Độ đưa 4.500 nhân viên đến Việt Nam du lịch là ai?

• Tỷ phú đưa 4.500 nhân viên sang Việt Nam du lịch giàu cỡ nào?